Country Industry Forecast - Economic Analysis for the United Kingdom Healthcare Industry


September 19, 2006
45 Pages - SKU: MC1375673
License type:
Countries covered: United Kingdom

Research Overview

After tourism and finance, healthcare is the most lucrative economic activity in the United Kingdom. The UK Government actively supports the growth of this industry by offering fiscal incentives and drafting investor-friendly policies that attract both domestic and foreign investors. The trade in pharmaceutical products has been profitable for the United Kingdom. Around 18 drugs of the world’s top 100 prescription drugs and nearly one in five best-selling drugs have been developed in the country. Many top pharmaceutical companies already have their major R&D center here in this country.

The U.K. government encourages production of generic drugs in the country by offering incentives to pharmacists and doctors for prescribing them. The over the counter (OTC) drugs market has experienced significant, though erratic growth in the last couple of years. The government’s aim to reduce healthcare costs is expected to result in the movement of an increasing number of prescription drugs to OTC status, thus giving a boost to this sub segment. The country encourages clinical trials through various tax incentives and favorable investment policies. However, low cost countries, such as India and China pose threats to the U.K. clinical trial market. The U.K. government has promised to increase R&D funding from the current 1.9 percent to 2.5 percent of the gross domestic product (GDP) by 2010. In addition, the country is making tremendous efforts to modernize the healthcare system in order to enhance the delivery of healthcare services and curb the rising healthcare cost. The reviving economy in the country is likely to increase investment, improve trade in pharmaceutical products and increase people’s purchasing power in the forecast period.

Frost & Sullivan’s Healthcare Country Industry Forecast service provides vital inputs for evaluating the attractiveness of a country and its healthcare industry. Besides enabling decision makers to assess the impact of non-market forces, it also helps identify new market opportunities. This service provides a strong base for preparing contingency plans. In addition, investors can assess industry-specific risk factors as well as conduct in-depth micro research.

Benefits of this Service

Identify New Market Opportunities

The future trends of the economic environment of the United Kingdom have been analyzed along with their impact on the healthcare industry. This analysis will provide valuable information to participants on opportunities in specific segments of the industry.

Understand Future Industry Trends

The research service gives an insight into the U.K. healthcare industry’s exports and import trends. This will enable industry participants to gauge the future direction of the market, enabling them to devise appropriate market strategies to improve market share.

Understand Policy and Regulatory Environment

A detailed analysis of the policy and regulatory framework of the U.K. healthcare industry will provide insights into the regulatory environment, as it exists, and its future.

Evaluate Industry Segment Potential

This research service offers detailed coverage of economic issues affecting the industry and their future direction. It provides country and industry trends with forecasts for major variables and is an excellent tool for companies that plan to enter new geographic markets. This will help corporate planners in developing accurate business plans and enhancing credibility to planning company resources.



More Drug Discovery reports by Frost & Sullivan

Analysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals by Frost & Sullivan
This research service is focused on the major bowel disorders and evaluates the market for oral and injectable prescription pharmaceuticals for the treatment of inflammatory ...
U.S. qPCR and dPCR Instrumentation Markets by Frost & Sullivan
This research service evaluates the U.S. quantitative polymerase chain reaction (qPCR) and digital PCR (dPCR) instrumentation markets from 2009 to 2016. Though related, they present ...
The United States Rheumatic Diseases Therapeutics Market by Frost & Sullivan
This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The ...
United States Market for Rheumatoid Arthritis Pharmacotherapeutics by Frost & Sullivan
This research service covers the United States rheumatoid arthritis pharmaceuticals market from 2009 to 2017, with 2011 as the base year. The focus of this ...
See all reports like this >>

More United Kingdom Drug Discovery reports

PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, “PharmaPoint: Multiple Sclerosis - United Kingdom ...
Legionella Control (UK) - Industry Report by Plimsoll Publishing Ltd.
Plimsoll Publishing’s UK Legionella Control Analysis provides a detailed overview of the UK Legionella Control market and delivers a comprehensive individual analysis on the top ...
Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, “PharmaPoint: Multiple Sclerosis - United Kingdom ...
PharmaPoint: Osteoporosis - UK Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Osteoporosis - UK Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, “PharmaPoint: Osteoporosis - UK Drug Forecast and Market ...
See all reports like this >>

More United Kingdom reports

Painters & Decorators - Scotland (UK) - Industry Report by Plimsoll Publishing Ltd.
Plimsoll Publishing’s UK Painters & Decorators - Scotland Analysis provides a detailed overview of the UK Painters & Decorators - Scotland market and delivers a ...
D&B Country RiskLine Report: The United Kingdom by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United Kingdom by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
United Kingdom: Country Profile by MarketLine
INTRODUCTIONThis report provides a detailed analysis of the United Kingdom, providing an overview of its political, economic and business environment, represented both textually and in ...
See all reports like this >>